[1]洪森,温金平,黄晓明,等.1999—2011年岑溪市艾滋病感染者及病人生存分析[J].实用预防医学,2013,20(6):681-683. [2]江洪波,谢年华,曹倍辈,等.武汉市艾滋病患者生存时间及影响因素分析[J].中国公共卫生,2013,29(8):1097-1101. [3]Abaasa AM,Todd J,Ekoru K,et al. Good adherence to HAART and improved survival in a community HIV /AIDS treatment and care programme: the experience of the AIDS support organization(TASO) ,Kampala,Uganda[J].BMC Health Services Research,2008,8:241. [4]Cohen MS,Chen YQ,McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy[J]. The New England Journal of Medicine,2011,365(6) : 493-505. [5]赵玉遂,荆波,刘少楠,等. HAART对AIDS患者中短期效果的Meta分析[J].中国艾滋病性病,2012,18(2):79-81. [6]Ewings FM, Bhaskaran K, Mclean K, et al. Survival following HIV infection of a cohort followed from seroconversion in the UK [J]. AIDS, 2008, 22(1):89-95. [7]Sieleunou I, Souleymanou M, Schonenberger AM, et al. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Tar North Province, Cameroon [J]. Trop Med Int Health, 2009, 14(1):36-43. [8]叶荣,李艳,李俊彬等. 广东省艾滋病感染者/患者的生存分析[J]. 华南预防医学, 2015, 41(2): 107-112. [9]刘学宁,冯铁建,陈琳,等.性别因素对HIV感染者免疫学功能变化和疾病进程的影响[J].中国性病艾滋病防治,2001,7(4):214-217. [10]彭文伟, 马亦林,王勤环, 等. 传染病学[M]. 北京: 人民卫生出版社,1999: 78- 79. [11]丁萍,张正红,陈国红,等.2005—2008年江苏省首次接受抗病毒治疗的艾滋病患者生存分析[J].南京医科大学学报(自然科学版),2012,32(10):1471-1475. |